🌟 Sugammadex (CAS 343306-71-8) - Product Overview
Sugammadex is a synthetic γ-cyclodextrin derivative (molecular formula: C₇₂H₁₁₂O₄₈S₈, MW: 2002.15) specifically engineered to reverse neuromuscular blockade induced by rocuronium or vecuronium during surgical procedures. With ≥99% HPLC purity and stability under 2-8°C storage, it is a critical pharmaceutical-grade agent for anesthesia recovery and emergency clinical use.
🔑 Key Advantages
✔️ Rapid Reversal: Achieves neuromuscular recovery within ≤3.6 minutes post-administration (2.5 mg/kg dose).
✔️ High Selectivity: Binds exclusively to rocuronium/vecuronium, preserving acetylcholine function.
✔️ Water Solubility: >50 mg/mL, optimized for injectable formulations.
✔️ Stability: Maintains integrity under inert atmospheric conditions.
📋 Applications
Surgical Anesthesia: Primary use for reversing neuromuscular blockade after surgery.
Emergency Antidote: Critical for urgent reversal of muscle relaxant overdoses.
Research: Studies on neuromuscular physiology and anesthesia optimization.
🏅 Quality Certifications
Complies with USP/EP pharmacopeial standards.
Rigorously tested via HPLC, GC, and NMR for batch consistency.
Produced under GMP guidelines in ISO-certified facilities.
📈 Market Trends
The global neuromuscular blockade reversal market is projected to grow significantly by 2030, driven by rising surgical volumes and demand for precision anesthesia solutions. Sugammadex remains a gold-standard agent due to its speed and safety profile.
China
